November 1st 2003

  Buy Issue 2669

Articles from this issue:

COVER STORY: France and Italy address fertility crisis

EDITORIAL: Bushfires: why the nightmare will be repeated

CANBERRA OBSERVED : Reforming the Senate?

MEDIA: Packer's media-gambling alliance

HEALTH: Abortion-Breast Cancer cover-up continues

FAMILY: Preserving marriage in Australia

AGRICULTURE: Mandate ethanol or sugar industry faces collapse

LETTERS: Time for farmers to wake up (letter)

LETTERS: New TV code of practice (letter)

LETTERS: Special needs, special treasures (letter)

LETTERS: New use for sugar cane trash (letter)

LETTERS: Nuclear menace (letter)

HEALTH WATCH: The 'morning after' pill: coming soon to a school near you?

WATER: Federals distance themselves from 'The Living Murray'

STRAWS IN THE WIND: Jim Cairns remembered

COMMENT: SBS programming questioned by Vietnamese community

ASIA: Siberia - China's 'great game' to reshape Asian region

COMMENT: Don't forget the threat from North Korea

Hong Kong: next elections a test for Beijing

Books promotion page

The 'morning after' pill: coming soon to a school near you?

by News Weekly

News Weekly, November 1, 2003
The potential availability of the "morning after" pill in UK schools raises warnings for Australia.

The Herald Express (October 4) has reported that school nurses in South Devon, UK, will soon be able to hand out the "morning after" pill to girls over eleven years of age without consulting the girl's doctor or parents.

School governors in the area will be responsible for deciding if the "morning after" pill, Levonelle 2, will be made available on site.

Decisions regarding eligibility for the pill will rest with nurses, who will have to decide "whether the girl is intelligent enough to fully understand"

Levonelle 2 is a relatively new "morning after pill" which its distributors have claimed is more reliable and has fewer side-effects.

Side effects

Despite claims of negligible side-effects, The Pharmaceutical Journal (Vol 264 No 7082 p231) reported on possible side-effects associated with taking Levonelle 2.

These included: breast tenderness, headache, dizziness and fatigue, temporary disturbances in menstruation, bleeding, spotting and early or delayed onset of menstruation.

Nausea occurs in about 25 per cent of women and vomiting in about 5 per cent.

There are also various contra-indications for taking Levonelle 2 which include an overdue period, if the last period was abnormal in timing or character, or if pregnancy is suspected for any other reason.

Many of these symptoms (abnormal and/or irregular periods) are common in young woman, especially those who have just commenced menstruating.

In the UK, Levonelle 2 has been available over the counter to women aged sixteen and over, since January 2001.

The Observer has reported that a million courses of the "morning after pill" are sold annually in Britain.

Does Levonelle 2, and other morning after contraceptives take the "worry" out of unsafe sex? Not likely.


It may however, open the floodgates to sexual experimentation, in a climate where sexually transmitted diseases and sexually transmitted infections are rife.

With the value of hindsight, some members of the UK Royal College of Nurses expert adolescent health team have voiced concern that over-the-counter sales of the "morning after pill" result in women not having the time or privacy to discuss preventative health measures.

Hence, there is a rise in risky and unsafe sex.

It seems alarming that girls younger than sixteen may soon have access to a morning after pill, when they obviously do not understand the risks or responsibilities that accompany sexual intimacy.

Allowing Levonelle 2 to be made available to young women in the school grounds has nothing to do with sex education - it is an issue that relates to sexual maturity - something unlikely to exist in recently post-pubescent girls.

Australia following suit?

Locally, the push for accessibility to over the counter "morning after pills", otherwise known as emergency contraception (EC), is following suit with other countries.

Richard Egan reported in News Weekly (May 31, 2003) of a submission to the National Drugs and Poisons Schedule Committee (NDPSC) to have Postinor-2 (Levonelle 2's Australian trading name) changed from a prescription only drug (Schedule 4) to a pharmacists only drug (Schedule 3), effectively allowing women to gain greater access to the abortifacients over the counter.

In June this year, Levonelle 2 was altered from a Schedule 4 to a Schedule 3 drug, implementing this change.

If Australia follows this growing trend of making emergency contraception available to all, in a few years Levonelle 2, and other such "morning after" pills, may be available on site in Australian schools.

All you need to know about
the wider impact of transgenderism on society.
TRANSGENDER: one shade of grey, 353pp, $39.99

Join email list

Join e-newsletter list

Your cart has 0 items

Subscribe to NewsWeekly

Research Papers

Trending articles

COVER STORY Coronavirus: China must answer hard questions

NATIONAL AFFAIRS Cardinal Pell's appeal in the High Court this week

CLIMATE POLITICS Business joins Big Brother in climate-change chorus

COVER STORY Beyond the Great Divide

COVER STORY Murray River full; reservoirs low; farms for sale ...

ILLICIT DRUGS Cannabis marketed to children in Colorado

EDITORIAL Holden, China, covid19: Time for industry reset

© Copyright 2017
Last Modified:
April 4, 2018, 6:45 pm